Silver nanoparticles as antimicrobial therapeutics: current perspectives and future challenges.

Area of Science:

• Nanotechnology
• Microbiology
• Materials Science

Background:

• The historical use of silver in antimicrobial therapy has declined due to silver-resistant strains and the rise of antibiotics.
• The widespread overuse and misuse of antibiotics have led to the emergence of multi-drug resistant (MDR) 'superbugs', posing a significant global health threat.
• Limited new antibiotic development necessitates exploring alternative therapeutic strategies, reviving interest in silver-based antimicrobials.

Purpose of the Study:

• To review green synthesis methods for silver nanoparticles (AgNPs).
• To elucidate the mechanisms by which AgNPs inhibit microbial growth.
• To investigate the synergistic effects of AgNPs when combined with conventional antibiotics and discuss future challenges for nano-silver therapeutics.

Main Methods:

• Literature review focusing on green synthesis of AgNPs.
• Analysis of studies detailing the antimicrobial mechanisms of AgNPs.
• Examination of research on the combined efficacy of AgNPs and antibiotics.

Main Results:

• Green synthesis offers a sustainable approach for AgNP production.
• AgNPs exhibit broad-spectrum antimicrobial activity through multiple mechanisms.
• Synergistic effects between AgNPs and antibiotics show enhanced efficacy against MDR bacteria.

Conclusions:

• Silver nanoparticles represent a promising therapeutic avenue for combating MDR infections.
• Further research into green synthesis and synergistic applications is crucial for developing effective nano-silver-based treatments.
• Addressing challenges in AgNP development is key to realizing their full potential in antimicrobial therapy.